Skip to main content

Advertisement

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Conference Coverage

Use of Fertility Preservation and Assisted Reproductive Technologies to Attempt Pregnancy Among Patients With Breast Cancer

Featuring Hatem Azim, MD, PhD

 

Hatem Azim, MD, PhD, Monterrey Institute of Technology, Nuevo León, Mexico discussed results from the POSITIVE trial which found that young age was the main factor associated with shorter time to pregnancy among patients with hormone receptor-positive breast cancer. 

These results were first reported at the 2023 San Antonio Breast Cancer Symposium. 


Source: 

Azim H, Niman S, Partridge A, et al. Fertility preservation and assisted reproductive technologies (ART) in breast cancer (BC) patients (pts) interrupting endocrine therapy (ET) to attempt pregnancy. Presented at the 2023 San Antonio Breast Cancer Symposium; December 5-9; San Antonio, Texas. Abstract GS02-11 

© 2023 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Oncology Learning Network or HMP Global, their employees, and affiliates. 

Advertisement

Advertisement

Advertisement

Advertisement